SIRT2 and neoplasm: SIRT2 is generally considered a tumor suppressor because its expression is downregulated in most cancers, and it restricts cell cycle progression by deacetylating cell cycle-related factors and deacetylating H4K16 to allow chromatin condensation (30,37,41,67–71).